PRESS-RELEASE ·Filed Apr 16, 2026
Press release: earnings
Actionable Insight • Neutral
No trading-relevant information was disclosed. Traders should monitor the upcoming earnings call on April 30 for actual results and guidance. The prior period miss suggests caution if trends are continuing.
Final — all horizons settled through T+60d ⚠ clustered
EBS ▼ -14.87% at T+60d
NEUTRAL call ✗ call lost -14.87% · α vs SPY -21.01% · entry $8.81 → $7.50
T+1d
-5.22%
call -5.22% · α -5.03%
$8.35
settled 6mo ago
T+5d
-8.85%
call -8.85% · α -9.41%
$8.03
settled 5mo ago
T+20d
-6.81%
call -6.81% · α -12.18%
$8.21
settled 5mo ago
T+60d
-14.87%
call -14.87% · α -21.01%
$7.50
settled 3mo ago
Price Chart
Loading chart...
Executive Summary
Emergent BioSolutions announced a future earnings call for Q1 2026 but did not release actual financial results in this filing. No new operational or financial data was disclosed, making this a routine scheduling notice.
Key Facts
- Company will host a conference call on April 30, 2026, to discuss Q1 2026 financial results
- No actual financial results were released in this filing
- Earnings context shows consensus estimates: EPS $-0.25, Revenue $160.5M for an unspecified prior period (possibly Q4 2025)
- Reported EPS of $-0.43 represents a 72% miss, but this appears to be stale or misattributed data as it contradicts the forward-looking nature of the press release
Financial Impact
No financial impact from this filing
Risk Factors
- Lack of transparency around which period the reported EPS of $-0.43 refers to
- Potential for negative sentiment if Q1 2026 results follow prior weakness
Market Snapshot
Exchange
NYSE
Sector
Pharmaceutical Preparations
Investment Themes
Biotech & Drug Discovery
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3275808 |
16 reports for EBS
60% Hit rate best @ T+20▲ +14.89%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 10, 2026 7w ago | Press Release | $4.45 $5.68 | ▼ −27.64% | ▼ −28.70% | $6.29 (−41.35%) |
Jun 29, 2026 13w ago | 8-K | $8.46 $7.26 | ▼ −14.18% | ▼ −13.90% | $6.29 (−25.65%) |
Jun 4, 2026 17w ago | Press Release | $8.44 $8.28 | ▼ −1.90% | ▼ −0.52% | $6.29 (−25.47%) |
Apr 30, 2026 22w ago | Press Release | $8.47 $8.49 | ▲ +0.24% | ▼ −5.05% | $6.29 (−25.74%) |
Apr 30, 2026 22w ago | Insider Cluster | $8.23 $9.18 | ▲ +11.54% | ▲ +6.58% | $6.29 (−23.57%) |
Apr 29, 2026 22w ago | Press Release | $7.99 $9.18 | ▲ +14.89% | ▲ +8.85% | $6.29 (−21.28%) |
Apr 29, 2026 22w ago | Press Release | $7.99 $9.18 | ▲ +14.89% | ▲ +8.85% | $6.29 (−21.28%) |
Apr 28, 2026 22w ago | DEFA14A | $8.23 $9.13 | ▲ +10.94% | ▲ +5.47% | $6.29 (−23.57%) |
Apr 28, 2026 22w ago | Press Release | $8.23 $9.13 | ▲ +10.94% | ▲ +5.47% | $6.29 (−23.57%) |
Apr 27, 2026 22w ago | DEFA14A | $8.23 $9.13 | ▲ +10.94% | ▲ +5.47% | $6.29 (−23.57%) |
Showing 10 of 16
US Market Status
Market Open — Closes in 2h 17m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access